Managing adverse drug reactions: an orphan task
Sue Jordan MB BCh PhD PGCE
Lecturer, School of Health Science, University of Wales, Swansea, UK
Search for more papers by this authorSue Jordan MB BCh PhD PGCE
Lecturer, School of Health Science, University of Wales, Swansea, UK
Search for more papers by this authorAbstract
Managing adverse drug reactions: an orphan task
Background. Nurse prescribing initiatives have potential to impact on medication management for long-term conditions. Over time, the adverse effects of medications become increasingly onerous. This `side-effect burden' is particularly heavy for users of antipsychotic medication. Although consensus exists that strategies are needed to alleviate these problems, currently, they are not clearly the responsibility of any one professional group.
Aim. This paper explores the introduction of nurse-administered evaluation checklists, in relation to nurse prescribing initiatives and division of professional responsibilities for medication management.
Methods. This was an observation study, with a quasi-experimental comparator group design, undertaken with clients receiving long-term antipsychotic medication. In both intervention and comparator groups, before and after introduction of evaluation checklists in the intervention group, 20 nurse–client interactions were observed. Problems actioned by the nurses, with and without the checklists, were compared. Stakeholders' views were sought concurrently.
Findings. Implementation of evaluation checklists increased the numbers of adverse effects detected and actioned by nurses. They also served to apportion aspects of medication management between nurses and medical prescribers. Most actions taken by nurses to alleviate adverse effects concerned clients' physical health and advice on health-promotion. However, the nurses' interventions would have been more effective had they been able to supply clients with certain medicines either by prescribing from the Nurse Prescribers' Formulary or issuing under Patient Group Directions. For some clients, ameliorating the adverse effects of medication would have involved changes to prescribed antipsychotic medication; here decisions were more equivocal.
Implications. The identification of previously unattended problems, together with the views of service users, suggests that empowering nurses to address the `care gaps' in medication management may benefit service users. The `checklist evaluation' approach warrants further investigation, ideally in conjunction with nurse prescribing initiatives.
References
- 1 Allen J. (1998) A survey of psychiatric nurses' opinions of advanced practice roles. Journal of Psychiatric Mental Health Nursing 5, 451–462.
- 2 Awad A.G. (1999) Behavioural and subjective effects. In Managing the Side Effects of Drug Therapy in Schizophrenia (Kane J.M. ed.), Science Press, London, pp. 1–14.
- 3 Awad A.G., Voruganti L. & Heslegrave R. (1997) Measuring quality of life in patients with schizophrenia. Pharmacoeconomics 11, 32–47.
- 4
Barlow S. (1994) Drawing up a schedule for observation.
Nurse Researcher
2, 22–29.
10.7748/nr.2.2.22.s4 Google Scholar
- 5 Barnes T. (1989) A rating scale for drug-induced akathisia. British Journal of Psychiatry 154, 672–676.
- 6 Barr O., Gilgunn J., Kane T. & Moore G. (1999) Health screening for people with learning disabilities by community learning disability nursing service in Northern Ireland. Journal of Advanced Nursing 29, 1482–1491.
- 7 Bennett J., Done J., Harrison-Read P. & Hunt B. (1995) Development of a rating scale/checklist to assess the side effects of antipsychotics by community psychiatric nurses. In Community Psychiatric Nursing: A Research Perspective (Brooker C. & White E. eds), Vol. 3, Chapman & Hall, London, pp. 1–19.
- 8 Bentley H. & Leatham J. (1998) Nurse prescribing: a critical evaluation of training. Primary Health Care 8, 712–716.
- 9 BNF (2001) British National Formulary No. 42. British Medical Association and the Royal Pharmaceutical Society of Great Britain, London.
- 10 Bodenheimer T. (1999) Disease management – problems and pitfalls. New England Journal of Medicine 340, 1202–1205.
- 11 Borgaonkar M. & Irvine E. (2000) Quality of life measurement in gastrointestinal and liver disorders. Gut 47, 444–454.
- 12 Brooks N., Otway C., Rashid C., Kilty L. & Maggs C. (2001) Nurse prescribing: what do patients think? Nursing Standard 15, 33–38.
- 13 Brunton L. (1996) Agents affecting gastrointestinal water flux and motility: emesis and antiemetics: bile acids and pancreatic enzymes. In Goodman and Gilman's: The Pharmacological Basis of Therapeutics (Hardman J., Limbard L., Molinoff P., Ruddon R. & Goodman Gilman A. eds), 9th edn. McGraw-Hill, New York, pp. 917–936.
- 14 Buchanan A. (1992) A two-year prospective study of treatment compliance in patients with schizophrenia. Psychological Medicine 22, 787–797.
- 15 Burns T., Millar E., Garland C., Kendrick T., Chisolm B. & Ross F. (1998) Randomized controlled trial of teaching practice nurses to carry out structured assessment of patients receiving depot antipsychotic injections. British Journal of General Practice 48, 1845–1848.
- 16 Chouinard G., Ross-Chouinard A. & Annable L. (1980) Extrapyramidal symptom rating scale. Canadian Journal of Neurological Science 7, 233233.
- 17 Cochrane A. (1972) Effectiveness and Efficiency. Nuffield Provincial Hospital Trust, London.
- 18 Cohen D., Littenberg B., Wetzel C. & Neuhauser D. (1982) Improving physician compliance with preventive medicine guidelines. Medical Care XX, 1040–1045.
- 19 Cortese L., Pourcher-Bouchard E. & Williams R. (1998) Assessment and management of antipsychotic-induced adverse events. Canadian Journal of Psychiatry 43 S1, 15–20.
- 20 Cunningham Owens D. (1999) A Guide to the Extrapyramidal Side-Effects of Antipsychotic Drugs. Cambridge University Press, Cambridge.
- 21 Davis R., Wagner E. & Groves T. (1999) Managing chronic disease. British Medical Journal 318, 1090–1091.
- 22 Day P., Klein R. & Miller F. (1998) Hurdles and Levers, a Comparative US–UK Study of Guidelines. Nuffield Trust, London.
- 23 Day J., Wood G., Dewey M. & Bentall R. (1995) A self-rating scale for measuring neuroleptic side-effects. British Journal of Psychiatry 166, 650–653.
- 24 Dixon L., Weiden P.J., Frances A.J. & Rapkin B. (1989) Management of neuroleptic-induced movement disorders, effects of physician training. American Journal of Psychiatry 146, 104–106.
- 25 Dixon L., Postrado L., Delahanty J., Fischer P. & Lehman A. (1999) The association of medical comorbidity in schizophrenia with poor physical and mental health. Journal of Nervous and Mental Disease 187, 496–502.
- 26 DoH (1989) Report of the Advisory Group on Nurse Prescribing Headed by Crown J. HMSO, London.
- 27 DoH (1997) The New NHS: Modern, Dependable. HMSO, London.
- 28 DoH (1999) Review of Prescribing, Supply and Administration of Medicines. HMSO, London.
- 29 DoH (2000a) Consultation Paper on the Extension of Nurse Prescribing. HMSO, London.
- 30 DoH (2000b) A Health Service of all the Talents: Developing the NHS Workforce. HMSO, London.
- 31 DoH (2001a) Identifying Nurses for Extended Nurse Prescribing Preparation in England. HMSO, London.
- 32 DoH (2001b) Medicines and Older People: National Service Framework. HMSO, London.
- 33 Feder G., Griffiths C., Highton C., Eldridge S., Spence M. & Southgate L. (1995) Do clinical guidelines introduced with practice based education improve care of asthmatic and diabetic patients? British Medical Journal 311, 1473–1478.
- 34 Gandhi T., Burstin H., Cook F., Puopolo A., Haas J., Brennan T. & Bates D. (2000) Drug complications in outpatients. Journal of General Internal Medicine 15, 149–154.
- 35 Gardos G. (1999) Managing anti-psychotic-induced tardive dyskinesia. Drug Safety 20, 187–193.
- 36 Goldman R.S. (1999) Cognitive effects of typical and atypical antipsychotic medications in schixophrenia. In Managing the Side Effects of Drug Therapy in Schizophrenia (Kane J.M. ed.), Science Press, London, pp. 15–25.
- 37 Gournay K. & Gray R. (2001) Should Mental Health Nurses Prescribe? Maudsley Discussion Paper No. 11. Institute of Psychiatry, King's College, London.
- 38 Greco P. & Eisenberg J. (1993) Changing physicians' practices. New England Journal of Medicine 329, 1271–1274.
- 39 Grimshaw J. & Russell I. (1993) Effect of clinical guidelines on medical practice. Lancet 342, 1317–1322.
- 40 Grol R., Dalhuijsen J., Thomas S., Veld C., Rutten G. & Mokkink H. (1998) Attributes of clinical guidelines that influence use of guidelines in general practice. British Medical Journal 317, 858–861.
- 41 Guy W. (1976) ECDEU Assessment Manual for Psychopharmacology. US Department of Health, Education and Welfare, Washington, DC.
- 42 Hanlon J.T., Schmader K., Ruby C. & Weinberger M. (2001) Suboptimal prescribing in older inpatients and outpatients. Journal of the American Geriatric Society 49, 200–209.
- 43
Hart J.T. (1971) The Inverse Care Law.
Lancet
1971i, 405–412.
10.1016/S0140-6736(71)92410-X Google Scholar
- 44 Hemingway S., Flowers K. & Ramcharan P. (2001) Nurse prescribing – an interim report: what do you think? Mental Health Nursing 21, 6–10
- 45 Henry W. (1993) Managing chronic health conditions is a critical need ignored by many. Trustee 46, 20–21.
- 46 Holloway F. (1988) Prescribing for the long-term mentally ill. British Journal of Psychiatry 152, 511–515.
- 47 Hulscher M., Wensing M., Grol R., Van Der Weijden T. & Van Weel C. (1999) Interventions to improve delivery of preventive services in primary care. American Journal of Public Health 89, 737–746.
- 48 Irvine D. (1999) The performance of doctors: the new professionalism. Lancet 353, 1174–1177.
- 49 Jones A. (2001) Hospital care pathways for patients with schizophrenia. Journal of Clinical Nursing 10, 58–69.DOI: 10.1046/j.1365-2702.2001.00435.x
- 50 Jordan S. & Hughes D. (1996) Bioscience knowledge and the health care professions. Social Science in Health 2, 80–92.
- 51 Jordan S., Coleman M., Hardy B. & Hughes D. (1999a) Assessing educational effectiveness: the impact of a specialist course on the delivery of care. Journal of Advanced Nursing 30, 796–807.DOI: 10.1046/j.1365-2648.1999.01176.x
- 52 Jordan S., Hardy B. & Coleman M. (1999b) Medication management: an exploratory study into the role of Community Mental Health Nurses. Journal of Advanced Nursing 29, 1068–1081.DOI: 10.1046/j.1365-2648.1999.01002.x
- 53 Jordan S., Tunnicliffe C. & Sykes A. (2002) Minimising side effects: the clinical impact of nurse-administered `side effect' checklists. Journal of Advanced Nursing 37, 155–165.DOI: 10.1046/j.1365-2648.2002.02064.x
- 54 Julien R. (1998) Drug Action, 8th edn. Freeman, New York.
- 55
Kalachnik J. &
Sprague R. (1993) The Dyskinesia Identification System Condensed User Scale (DISCUS).
Journal of Clinical Psychology
49, 177–189.
10.1002/1097-4679(199303)49:2<177::AID-JCLP2270490208>3.0.CO;2-# CAS PubMed Web of Science® Google Scholar
- 56 Kendrick T., Burns T., Freeling P. & Sibbald B. (1994) Provision of care to general practice patients with disabling long-term mental illness. British Journal of General Practice 44, 301–305.
- 57 Kinnersley P., Anderson E., Parry K., Clement J., Archard L., TurtonP., Stainthorpe A., Fraser A., Butler C. & Rogers C. (2000) Randomised controlled trial of nurse practitioner versus general practitioner care for patients requesting same day consultations in primary care. British Medical Journal 320, 1043–1048.
- 58 Kirkwood B. (1988) Essentials of Medical Statistics. Blackwell Science, Oxford.
- 59 Larsen G. (1999) Subjective experience and mental side-effects of antipsychotic treatment. Acta Psychiatrica Scandinavia S395, 113–117.
- 60 Lee Y. & Schommer J. (1996) Effect of a pharmacist-managed clinic on warfarin-related hospital readmissions. American Journal of Health System Pharmacy 53, 1580–1583.
- 61 Lehman A., Steinwachs D. and the Survey Co-Investigators of the PORT Project (1998) Patterns of usual care for schizophrenia: initial results from the schizophrenia patient outcomes research team (PORT) client survey. Schizophrenia Bulletin 24, 11–20.
- 62 Lenert L., Ziegler J., Lee T., Sommi R. & Mahmoud R. (2000) Differences in health values among patients, family members and providers for outcomes in schizophrenia. Medical Care 38, 1011–1021.DOI: 10.1097/00005650-200010000-00005
- 63 Leveille S., Wagner E., Davis C., Grothaus L., Wallace J., LoGerfo M. & Kent D. (1998) Preventing disability and managing chronic illness. Journal of the American Geriatric Society 46, 1191–1198.
- 64 Lewis G. & Wessely S. (1992) The epidemiology of fatigue: more questions than answers. Journal of Epidemiology and Community Health 46, 92–97.
- 65
Lingjaerde O.,
Ahlfors U.,
Bech P.,
Dencker S.J. &
Elgen K. (1987) The UKU side effect rating scale.
Acta Psychiatrica Scandinavia
76, 11–100.
10.1111/j.1600-0447.1987.tb10566.x Google Scholar
- 66 Luker K., Hogg C., Austin L., Ferguson B. & Smith K. (1998a) Decision making: the context of nurse prescribing. Journal of Advanced Nursing 27, 657–665.
- 67 Luker K., Austin L., Hogg C., Ferguson B. & Smith K. (1998b) Nurse-patient relationships: the context of nurse prescribing. Journal of Advanced Nursing 27, 235–242.
- 68 Mamo D.C., Sweet R.A. & Keshavan M.S. (1999) Managing anti-psychotic-induced Parkinsonism. Drug Safety 20, 269–275.
- 69 Marland G. (1999) Atypical neuroleptics: autonomy and compliance. Journal of Advanced Nursing 29, 615–622.DOI: 10.1046/j.1365-2648.1999.00930.x
- 70 Marshall J., Edwards C. & Lambert M. (1997) Administration of medicines by emergency nurse practitioners according to protocols in an accident and emergency department. Journal of Accident and Emergency Medicine 14, 233–237.
- 71 McCartney W., Tyrer S., Brazier M. & Prayle D. (1999) Nurse prescribing: radicalism or tokenism. Journal of Advanced Nursing 29, 348–354.DOI: 10.1046/j.1365-2648.1999.00895.x
- 72 McDowell I. & Jenkinson C. (1996) Development standards for health measures. Journal of Health Services Research Policy 1, 238–246.
- 73 McKenry L. & Salerno E. (1998) Pharmacology in Nursing, 19th edn. Mosby, St Louis, MO.
- 74 McShane R., Keene J., Gedling K., Fairburn C., Jacoby R. & Hope T. (1997) Do neuroleptic drugs hasten cognitive decline in dementia? British Medical Journal 314, 266–270.
- 75 Medicines Control Agency (2001) Extended Prescribing of Prescription Only Medicines by Independent Nurse Prescribers. Medicines Control Agency, London.
- 76 Millar E., Garland C., Ross F., Kendrick T. & Burns T. (1999) Practice nurses and the care of patients receiving depot neuroleptic treatment: views on training, confidence and use of structured assessment. Journal of Advanced Nursing 29, 1454–1461.DOI: 10.1046/j.1365-2648.1999.01033.x
- 77 Mitchell J.C. (1983) Case and situation analysis. Sociological Review 31, 187–211.
- 78 Murphy E., Dingwall R., Gratbatch D., Parker S. & Watson P. (1998) Qualitative research methods in health technology assessment: a review of the literature. Health Technology Assessment 2, 1616.
- 79 NHS (National Health Service) Executive (2000) Patient Group Directions [England Only]. NHS Executive, London.
- 80 Nolan M. & Grant G. (1993) Service evaluation: time to open both eyes. Journal of Advanced Nursing 18, 1434–1442.
- 81 Ong B.N. (1993) The Practice of Health Services Research. Chapman & Hall, London.
- 82 Patton M.Q. (1997) Utilization-Focused Evaluation, 3rd edn. Sage, Thousand Oaks, CA.
- 83 Peuskens J. (1998) Good medical practice in antipsychotic pharmacotherapy. International Clinical Psychopharmacology 13 (Suppl. 3), S35–S41.
- 84 Pill R., Stott N., Rollnick S. & Rees M. (1998) A randomized controlled trial of an intervention designed to improve the care given in general practice to Type II diabetic patients: patient outcomes and professional ability to change behaviour. Family Practice 15, 229–235.
- 85 Pill R., Rees M., Stott N. & Rollnick S. (1999) Can nurses learn to let go? Issues arising from an intervention designed to improve patients' involvement in their own care. Journal of Advanced Nursing 29, 1492–1499.
- 86 Platt J. (1988) What can case studies do? In Studies in Qualitative Methodology (Burgess R. ed.), Vol. 1, JAI Press, Greenwich, CT, pp. 1–23.
- 87 Sackett D., Haynes R.B., Guyatt G. & Tugwell P. (1991) Clinical Epidemiology: A Basic Science for Clinical Medicine, 2nd edn. Little, Brown, Boston, MA.
- 88 Sandford T. (1996) Involving users in developing depot phenothiazine services. In Perspectives in Mental Health Nursing (Sandford T. & Gournay K. eds.), Bailliere Tindall, London, pp. 165–92.
- 89 Shum C., Humphreys A., Wheeler D., Cochrane M., Skoda S. & Clement S. (2000) Randomised controlled trial comparing cost effectiveness of general practitioners and nurse practitioners in primary care. British Medical Journal 320, 1038–1043.
- 90
Simpson G.M. &
Angus J. (1970) A rating scale for extrapyramidal side effects.
Acta Psychiatrica Scandinavia
46, 11–19.
10.1111/j.1600-0447.1970.tb02066.x Google Scholar
- 91 Smith G. & Cantley C. (1985) Assessing Health Care. Open University Press, Milton Keynes.
- 92 Soumerai S., McLaughlin T. & Avorn J. (1989) Improving drug prescribing in primary care. Milbank Quarterly 67, 268–317.
- 93 Stockley I. (1999) Drug Interactions, 5th edn. Pharmaceutical Press, London.
- 94 Sullivan G., Wells K. & Leake B. (1992) Clinical factors associated with better quality of life in a seriously mentally ill population. Hospital and Community Psychiatry 43, 794–798.
- 95 UKCC (United Kingdom Central Council for Nursing, Midwifery and Health Visiting) (1999) A Higher Level of Practice: Draft Descriptor and Standards. UKCC, London.
- 96 Van Putten T. (1974) Why do schizophrenic patients refuse to take their drugs? Archives of General Psychiatry 31, 67–72.
- 97 Wagner E. (1998) Chronic disease management. Effective Clinical Practice 1, 2–4.
- 98 Warner J., King M., Blizard R., McClenahan Z. & Tang S. (2000) Patient-held shared care records for individuals with mental illness. British Journal of Psychiatry 177, 319–324.
- 99 Watt I.S., Franks A. & Sheldon T. (1994) Health and health care of rural populations in the UK: is it better or worse? Journal of Epidemiology and Community Health 48, 16–21.
- 100 Weiden P.J., Mann J., Haas G., Matttson M. & Frances A. (1987) Clinical nonrecognition of neuroleptic-induced movement disorders: a cautionary study. American Journal of Psychiatry 144, 1148–1153.
- 101 Whitney E., Cataldo C., DeBruyne L. & Rolfes S. (2001) Nutrition for Health and Health Care, 2nd edn. Wadsworth, Belmont, CA.
- 102 Yin R. (1994) Case Study Research: Design and Methods. Applied Social Research Methods Series, Vol. 5. Sage, Thousand Oaks, CA.
- 103 Yuen E., Gerdes J. & Gonzales J. (1996) Patterns of rural mental health care. An exploratory study. General Hospital Psychiatry 18, 14–21.DOI: 10.1016/0163-8343(95)00099-2